Trial Profile
An Open Label Randomized Two-way Crossover Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on the Single Oral Dose Pharmacokinetics of Tamsulosin in Healthy Male Volunteers (CYP2D6 Extensive Metabolizers)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary) ; Ketoconazole
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 22 Oct 2014 New trial record